Mechanisms of Action and Clinical Indications for Encala, a New Structured Lipid Nutritional Therapy
Dr. Virginia Stallings is Professor of Pediatrics at Children’s Hospital of Philadelphia at the University of Pennsylvania Perelman School of Medicine. Dr Stallings and her collaborators conduct clinical research in the nutrition-related growth, body composition and dietary abnormalities of infants, children and adolescents with chronic diseases. Studies have included children with cystic fibrosis, sickle cell disease, cerebral palsy, congenital heart disease, liver diseases, inflammatory bowel disease, HIV/AIDS, osteoporosis and obesity. In addition, our research group investigated the growth and developmental patterns of healthy children to establish reference standards for nutrition, growth, body composition, bone health and energy expenditure and requirements.Her clinical expertise is in nutrition and growth-related complications of chronic disease, nutrition support of hospitalized children, and long term advanced nutrition support of children. Dr Stallings is actively involved in nutrition and health policy for children and their mothers. Through work at the National Academy of Science and the Institute of Medicine, she makes ongoing contributions to improving the foods in the WIC program and in the school setting (breakfast, lunch, competitive foods) with the program leaders at the United States Department of Agriculture and Health and Human Services.
Dr. Stallings will present a seminar entitled, "Mechanisms of Action and Clinical Indications for Encala, a New Structured Lipid Nutritional Therapy," on Wednesday, October 20th at 11:30am.
*If you are interested in attending this Seminar, please email Staff Support, Amber Tweebeeke, to receive the Zoom link and password.